APA (7th ed.) Citation

G, P., F, L., L, G., P, D., T, M., K, L., . . . F, R. (2010). Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival. Clinical cancer research : an official journal of the American Association for Cancer Research, 16(8), 2363. https://doi.org/10.1158/1078-0432.CCR-09-1779

Chicago Style (17th ed.) Citation

G, Picarda, et al. "Preclinical Evidence That Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 16, no. 8 (2010): 2363. https://doi.org/10.1158/1078-0432.CCR-09-1779.

MLA (9th ed.) Citation

G, Picarda, et al. "Preclinical Evidence That Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 16, no. 8, 2010, p. 2363, https://doi.org/10.1158/1078-0432.CCR-09-1779.